Hui Guo
Affiliations: | California Institute for Biomedical Research |
Area:
Infectious disease, Drug discovery, High-throughput screeningGoogle:
"Hui Guo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang Y, Fang C, Wang RE, et al. (2019) A tumor-targeted immune checkpoint blocker. Proceedings of the National Academy of Sciences of the United States of America |
| Harbut MB, Liu R, Yang B, et al. (2018) Small molecules targeting Mycobacterium tuberculosis type II NADH dehydrogenase with antimycobacterial activity. Angewandte Chemie (International Ed. in English) |
| Luo X, Fu G, Wang RE, et al. (2017) Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria. Nature Chemical Biology |
| Harbut MB, Vilchèze C, Luo X, et al. (2015) Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 112: 4453-8 |
| Zhang HM, Dai H, Hanson PJ, et al. (2014) Antiviral activity of an isatin derivative via induction of PERK-Nrf2-mediated suppression of cap-independent translation. Acs Chemical Biology. 9: 1015-24 |
| Chen C, Wang J, Guo H, et al. (2013) Three antimycobacterial metabolites identified from a marine-derived Streptomyces sp. MS100061. Applied Microbiology and Biotechnology. 97: 3885-92 |